CAM
MRVI icon

Connacht Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Connacht Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$242K Sell
24,155
-14,876
-38% -$163K 1.43% 42
2023
Q2 		$485K Buy
39,031
+8,062
+26% +$109K 1.65% 28
2023
Q1 		$434K Buy
30,969
+3,283
+12% +$47.2K 1.25% 81
2022
Q4 		$396K Buy
27,686
+15,779
+133% +$248K 0.8% 84
2022
Q3 		$304K Buy
11,907
+3,972
+50% +$99.7K 0.57% 95
2022
Q2 		$225K Sell
7,935
-1,760
-18% -$55.8K 0.32% 134
2022
Q1 		$342K Sell
9,695
-6,856
-41% -$230K 0.51% 105
2021
Q4 		$693K Sell
16,551
-12,018
-42% -$487K 0.8% 54
2021
Q3 		$1.4M Buy
+28,569
New +$1.39M 1.61% 36

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return